Document is current

Article History

Received: 22 May 2025

Accepted: 19 June 2025

First Online: 24 July 2025

Declarations

:

: Mariateresa Rossi has received personal fees for advisory board meetings from Sanofi, AbbVie, Novartis, and Cantabria. Alessandra Narcisi has served on advisory boards and received honoraria and research grants from multiple companies including Almirall, AbbVie, Leo Pharma, Celgene, Eli Lilly, Janssen, Novartis, Sanofi Genzyme, Amgen, and Boehringer Ingelheim. Antonio Costanzo has served as an advisory board member and consultant, and has received fees, speaker's honoraria, or participated in clinical trials for AbbVie, Almirall, Biogen, LEO Pharma, Eli Lilly, Janssen, Novartis, Pfizer, Sanofi Genzyme, and UCB Pharma. Silvia Mariel Ferrucci has been principal investigator in clinical trials for multiple companies including AbbVie, Almirall, Galderma, Leo Pharma, Sanofi, Amgen, Novartis, and Bayer, and has received honoraria for lectures from Novartis and Menarini. Francesca Manzo Margiotta has nothing to declare. Simone Ribero has received honoraria and served as a consultant or advisory board member for companies including AbbVie, Almirall, Leo Pharma, Eli Lilly, Novartis, Pfizer, and Sanofi Genzyme. Michela Ortoncelli has served as a consultant or advisory board member for AbbVie, Leo Pharma, and Sanofi Genzyme. Maddalena Napolitano has acted as speaker, consultant, and/or advisory board member for AbbVie, Eli Lilly, Leo Pharma, Novartis, and Sanofi. Anna Balato has received honoraria for participation in advisory boards or as a speaker for several pharmaceutical companies including AbbVie, Celgene, Janssen Cilag, Eli Lilly, Novartis, Pfizer, Sanofi Genzyme, and UCB Pharma. Francesco Loconsole received honoraria or served on advisory boards for AbbVie, Janssen Cilag, Novartis, Eli Lilly, and Sanofi. Piergiorgio Malagoli has been a speaker for AbbVie, Eli Lilly, Novartis, Janssen Cilag, Celgene, Leo Pharma, and Almirall. Maria Letizia Musumeci has served as an advisory board member and consultant and has received speaker's honoraria and trial fees for AbbVie, Almirall, Biogen, Eli Lilly, Janssen Cilag, Leo Pharma, and Novartis. Caterina Foti has received honoraria for participation in advisory boards, meetings, or lectures for AbbVie, Amgen, Pfizer, Sanofi, Novartis, Eli Lilly, Leo Pharma, Incyte, and Boehringer Ingelheim. Andrea Carugno has been a consultant, speaker, or participant in advisory boards for AbbVie, Almirall, Amgen, Boehringer Ingelheim, Eli Lilly, Janssen-Cilag, Leo Pharma, Novartis, Sanofi, and UCB Pharma. Massimo Gola has been a consultant and/or speaker, participated in advisory boards, and received personal fees from AbbVie, Almirall, Leo Pharma, Pfizer, and Sanofi. Mario Bruno Guanti has served as an advisory board member and/or consultant and received fees, honoraria, or participated in clinical studies for AbbVie, Leo Pharma, Sanofi Genzyme, Novartis, Cantabria, and Eli Lilly. Elena Pezzolo has been a consultant and speaker for Sanofi Genzyme, AbbVie, Leo Pharma, Novartis, Janssen, Almirall, Pfizer, Galderma, and Boehringer Ingelheim. Stefano Bighetti, Matteo Bianco, Francesco Messina, Francesca Gaiani, Angelo Valerio Marzano, Francesca Barei, Francesco Leo, Andrea Cosenza, Cataldo Patruno, Claudio Sciarrone, Federica Veronese, Anna Graziella Burroni, Carlotta Gurioli, Flavia Manzo Margiotta, Francesca Satolli, Giuseppe Amoruso, Maria Esposito, Paolo Pella, Nicola Zerbinati, Martina Maurelli, Ilaria Trave, Luca Bettolini have nothing to disclose. Mariateresa Rossi, Anna Campanati and PierGiacomo Calzavara-Pinton are Editorial Board members for Dermatology and Therapy. They were not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.

: Ethical approval was not required, as the study involved retrospective data collection without deviation from routine clinical care. All participants had provided written informed consent for the use of their anonymized clinical data during standard clinical visits. The study was conducted in accordance with the principles of the Declaration of Helsinki and relevant regulations regarding data protection and patient confidentiality. Data collection complied with all applicable regulations on patient protection and privacy. Informed consent was obtained from all subjects involved in the study.